Foram realizados cinco experimentos com o objetivo de sincronização do estro e indução da ovulação em tempo fixo em éguas. Experimento I: avaliou a eficácia de um novo protocolo hormonal para a sincronização do estro, sendo realizado durante o período transicional em éguas cujo status reprodutivo era desconhecido. Experimento II: foi delineado para determinar o momento ideal para retirada dispositivo intravaginal de progesterona (DIP), sendo o dispositivo retirado no dia 7, 8 ou 9 do protocolo de tratamento hormonal. Experimento III: testou se a eficiência do protocolo é dependente da fase do ciclo estral da égua e definiu o melhor momento para indução da ovulação. Experimentos IV e V: as éguas foram submetidas ao protocolo completo de sincronização da onda folicular e indução da ovulação em diferentes fases do ciclo estral ou com status reprodutivo conhecido. A hipótese testada foi de que a sincronização do estro e indução da ovulação, com o uso do DIP de 1,44g provoca a supressão do crescimento folicular e através da indução da ovulação, com hCG e GnRH, promove a ovulação dentro de 42 ± 6 horas de no mínimo 75% dos animais. Para isso, os efeitos das prostaglandinas e progestágenos foram avaliados quanto à capacidade de sincronizar a onda de crescimento folicular. Um novo tratamento para induzir a ovulação em tempo fixo foi testado com uma combinação de GnRH e hCG em dois momentos estratégicos (D10 e D12) visando maximizar o número de éguas ovuladas. O protocolo com administração de prostaglandina no D0, D6 e D8 juntamente com a colocação do DIP mantido durante 8 dias (D0 ao D7) demonstrou ser eficaz para suprimir a taxa de crescimento folicular em éguas cíclicas. Nas éguas submetidas a este protocolo as ovulações que ocorreram naturalmente se concentraram entre os dias 10 e 13 do tratamento. Foi testada a eficiência da indução da ovulação no D10 e D12. Na maioria dos animais tratados, o folículo pré-ovulatório foi responsivo à combinação de GnRH e hCG promovendo o sucesso da indução da ovulação. A eficiência do protocolo hormonal testado para sincronização do estro e da ovulação foi de 76,73%, sustentando a hipótese deste estudo. Novos estudos devem ser realizados em um maior número de animais para possíveis adequações na terapia hormonal e verificação do resultado em um grande número experimental de animais. / Five experiments were conducted with the objective of estrus synchronization and fixed time ovulation induction in mares. Experiment I: evaluated the efficacy of a new hormonal protocol for estrus synchronization in mares whose reproductive status was unknown during the transitional period. Experiment II: was designed to determine the best time to remove the P4 intravaginal device (PID). The device was removed on day 7, 8 or 9 of the hormonal treatment protocol. Experiment III: tested if protocol efficiency depends on the stage of mares estrus cycle and indicated the best time for hormonal induction of ovulation. Experiments IV and V: mares were submitted to the full protocol of follicular wave synchronization and ovulation induction at different stages of estrus cycle or at known reproductive status. The tested hypothesis was that the estrus synchronization and induction of ovulation, using an PID of 1.44g, causes suppression of follicular growth, and ovulation induction using hCG and GnRH promote ovulation within 42 ± 6 hours of at least 75% of treated animals. The effect of prostaglandin and progestagens at specific times were evaluated for the ability to synchronize follicular wave. A new treatment to induce fixed time ovulation was tested with GnRH and hCG combination in two strategic moments (D10 and D12) to maximize the number of ovulated mares. Administration of prostaglandin at D0, D6 and D8 together with PID maintained for 8 days (D0 to D7) proved to be effective to suppress follicular growth during reproductive period. In mares submitted to this protocol, ovulation occurred naturally and concentrated between D10 and D13. The ovulation induction efficiency was tested at D10 and D12. Most of the animals had preovulatory follicle responsiveness to GnRH and hCG, promoting the success of ovulation induction. The efficiency of the tested synchronization of estrus and ovulation induction protocol was 76.73% and supported the hypothesis of this study. Further studies should be performed on a larger number of animals for possible adjustments in hormonal therapy and verification of the result in a large number of animals.

Objectives were to determine: 1) whether estradiol benzoate (EB) provides a superior alternative to GnRH for synchronizing emergence, growth and maturation of a new follicular wave for fixed timed AI (TAI) in Bos indicus-influenced cattle using CIDR-based protocols, 2) the effect of 48 h calf removal at CIDR removal on the rate of maturational synchrony of the dominant follicle and 3) the effect of varying the magnitude of peak plasma progesterone (P4) concentrations following CIDR insertion on the suppression of FSH and LH secretion in a CIDR-based protocol using EB. In experiment 1, sixty-four Braford (F-1) females were stratified by BCS, parity and days postpartum and assigned randomly to one of four groups in a 2 x 2 factorial arrangement of treatments: 1) Select-Synch + CIDR, 2) Select-Synch + CIDR with 48 h calf removal, 3) E-Synch + CIDR or 4) E-Synch + CIDR with 48 h calf removal. A greater number of cattle in the EB treated group exhibited NFWE compared to the GnRH group, 29 vs 17 cows for EB and GnRH respectively, (P<0.0006). Intervals to NFWE were also greater in EB treated cattle than in GnRH treated cattle, 4.2 vs 2.7 d for EB and GnRH treated cattle respectively, (P<0.0001). Proportions of GnRH- and EB-treated cows ovulating after CIDR removal did not differ. Post-CIDR suckling status did not affect ovulation frequency or interval to ovulation. In experiment 2, eight pubertal (F-1) heifers were used in a Latin Square design with four treatment levels of P4: 1) EB only, 2) EB and new CIDR, 3) EB and new autoclaved CIDR, 4) EB, new autoclaved CIDR and P4 injection at CIDR insertion. Treatments 2 through 4 increased (P < 0.01) mean plasma P4 concentrations compared to treatment 1, with treatment 4 creating the greatest increase in P4 with the longest duration. Suppression of plasma FSH was greatest in group 4 (P<0.08), with mean 60 h concentrations less than in all other groups. Mean concentrations of LH were lesser in group 4 than groups 1 and 2. Frequencies of occurrence of NFWE and ovulation and intervals to NFWE did not differ among treatments. Results indicate that the use of EB and CIDR to synchronize Brahman x Hereford females may provide better synchronization for TAI compared to GnRH and CIDR based protocols.

To investigate the physiological action of follistatin in the swine ovary a recombinant porcine follistatin (rpFS) with apparent molecular weights of 39, 46, 48, and 50 kDa was expressed and characterized. The rpFS crossreacted with antibodies against native porcine follistatin and with activin A. One rpFS isotype was purified by monoclonal antibody affinity chromatography (rp-305 a.a. FS). In porcine granulosa cell cultures, rp-305 a.a. FS suppressed estradiol-17<math> <f> <g>b</g></f> </math> accumulation (ED50 = 0.9 <math> <f> <g>m</g></f> </math>g/ml) independent of activin. Gilts were vaccinated against rpFS to determine the effect of follistatin immunoneutralization on litter size or ovulation rate. In Experiment 1, forty-seven gilts were vaccinated four times with rpFS (FS n = 23) or with a control vaccine (CTL n = 24). The naturally matured, cycling gilts were bred and piglet numbers were recorded at farrowing. FS vaccination did not increase total litter size. However, grouping by low (<math> <f> <=</f> </math>1:400 n = 16) or high anti-follistatin antibody titer (>1:400 n = 7) responses showed an increased litter size in gilts with a high titer (total piglets: FS high titer = 13.0 ± 0.8; FS low titer = 10.8 ± 0.6; CTL 11.4 ± 0.5; p = 0.08). In Experiment 2, sixty-nine gilts were vaccinated three times with rpFS (n = 35) or CTL (n = 34) vaccines. The gilts were induced and synchronized into estrus using PG600, <math> <f> <rm>PGF<inf>2<g>a</g></inf></rm></f> </math> and boar exposure; cycling gilts received a fourth vaccination. Reproductive tracts were collected two weeks after the second observed estrus (FS n = 14, CTL n = 15). FS vaccination did not increase the number of corpora lutea (FS = 13.2 ± 0.5, CTL = 14.5 ± 0.7) or corpora albicantia (FS = 12.1 ± 1.9, CTL = 12.3 ± 2.0), but appeared to effect normal ovarian morphology increasing the number of blood-filled follicles and corpora lutea. In conclusion, rp-305 a.a. FS appears to negatively affect estradiol accumulation 'in vitro'. Vaccination against follistatin in naturally cycling gilts enhanced litter size. Follistatin vaccination of pharmacologically induced gilts did not increase ovulation rate, but biological effects were apparent suggesting that pharmacological induction of estrus may have confounded the follistatin vaccination treatment.

Objectives were to determine: 1) whether estradiol benzoate (EB) provides a superior alternative to GnRH for synchronizing emergence, growth and maturation of a new follicular wave for fixed timed AI (TAI) in Bos indicus-influenced cattle using CIDR-based protocols, 2) the effect of 48 h calf removal at CIDR removal on the rate of maturational synchrony of the dominant follicle and 3) the effect of varying the magnitude of peak plasma progesterone (P4) concentrations following CIDR insertion on the suppression of FSH and LH secretion in a CIDR-based protocol using EB. In experiment 1, sixty-four Braford (F-1) females were stratified by BCS, parity and days postpartum and assigned randomly to one of four groups in a 2 x 2 factorial arrangement of treatments: 1) Select-Synch + CIDR, 2) Select-Synch + CIDR with 48 h calf removal, 3) E-Synch + CIDR or 4) E-Synch + CIDR with 48 h calf removal. A greater number of cattle in the EB treated group exhibited NFWE compared to the GnRH group, 29 vs 17 cows for EB and GnRH respectively, (P<0.0006). Intervals to NFWE were also greater in EB treated cattle than in GnRH treated cattle, 4.2 vs 2.7 d for EB and GnRH treated cattle respectively, (P<0.0001). Proportions of GnRH- and EB-treated cows ovulating after CIDR removal did not differ. Post-CIDR suckling status did not affect ovulation frequency or interval to ovulation. In experiment 2, eight pubertal (F-1) heifers were used in a Latin Square design with four treatment levels of P4: 1) EB only, 2) EB and new CIDR, 3) EB and new autoclaved CIDR, 4) EB, new autoclaved CIDR and P4 injection at CIDR insertion. Treatments 2 through 4 increased (P < 0.01) mean plasma P4 concentrations compared to treatment 1, with treatment 4 creating the greatest increase in P4 with the longest duration. Suppression of plasma FSH was greatest in group 4 (P<0.08), with mean 60 h concentrations less than in all other groups. Mean concentrations of LH were lesser in group 4 than groups 1 and 2. Frequencies of occurrence of NFWE and ovulation and intervals to NFWE did not differ among treatments. Results indicate that the use of EB and CIDR to synchronize Brahman x Hereford females may provide better synchronization for TAI compared to GnRH and CIDR based protocols.

Two trials were conducted to quantify the effects of GnRH and prostaglandin in conjunction with a 7-d CIDR on estrus and on pregnancy rate in comparison with a traditional synchronization protocol. In trial 1, ewes (n=12) were randomly allotted to one of three treatments: CIDR (7 d) with administration of GnRH (Cystorelin®, 50μg, im) at CIDR insertion and PGF2α (Lutalyse®, 20 mg, im) on d 6.5 (GnRH1); the GnRH1 protocol with a second injection of GnRH 30 h after CIDR removal (GnRH2); and CIDR (11 d) with administration of PGF2α at CIDR insertion and PMSG (400 iu) at CIDR removal (PMSG). A blood sample was obtained every 2 h for 42 h after CIDR removal for serum LH analysis. On d 8 after CIDR removal, blood samples were obtained at 12 h intervals for 36 h for serum P4 analysis. One ewe in the GnRH1 group did not retain the CIDR device and was excluded from the analysis. Mean LH concentration did not differ (P = 0.48) among groups. Time and time x treatment affected (P < 0.001) mean LH concentration. Mean P4 concentration was not affected (P = 0.26) by time, treatment or their interaction. In trial 2, ewes (n=72) were randomly allotted to one of the three treatments described in trial 1. At CIDR removal, three ewes per treatment were joined with a single ram fitted with a marking harness in each of 8 pens. Ewes were monitored every hour for estrus activity and ultrasounded transabdominally 60 d after CIDR removal for pregnancy. Estrus activity did not differ (P > 0.05) among the groups. Marking frequency was 92 percent, 75 percent, and 88 percent for GnRH1, GnRH2, and PMSG groups, respectively. Mean interval to estrus was shorter (P < 0.05) for the GnRH2 than for the PMSG group and tended to be reduced (P < 0.10) compared with the GnRH1 group. Pregnancy rate differed (P < 0.05) among treatments (79 percent, 58 percent and 38 percent for GnRH1, GnRH2, and PMSG groups, respectively). These results indicate that synchrony of estrus and pregnancy rate to natural service can be increased in response to a CIDR protocol when combined with administration of GnRH rather than PMSG.

Thesis (M.S.)--University of Missouri-Columbia, 2007. / The entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Title from title screen of research.pdf file (viewed on March 31, 2008) Vita. Includes bibliographical references.

Thesis (Ph. D.)--University of Adelaide, 1985. / Includes bibliographical references (leaves 182-210).

Thesis (M.Ag.Sc.)--University of Adelaide, Dept. of Animal Physiology, 1980. / Includes bibliographical references (leaves 193-205).

Thesis (M.S.)--University of Missouri-Columbia, 2007. / The entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Title from title screen of research.pdf file (viewed on April 9, 2009) Vita. Includes bibliographical references.

Thesis (Ph. D.)--Florida State University, 2006. / Advisor: Thomas A. Houpt, Florida State University, College of Arts and Sciences, Dept. of Neuroscience. Title and description from dissertation home page (viewed June 12, 2006). Document formatted into pages; contains xiv, 112 pages. Includes bibliographical references.